Real‐world genetic testing outcomes of pan‐cancer testing for mismatch repair deficiency von Chai, Teresa S., Rodgers‐Fouche, Linda H., Walls, Jenna O., Mattia, Anthony R., Chung, Daniel C.

Volltext

Reply to "Expansion of pan-cancer mismatch repair testing: Implications for pembrolizumab eligibility and Lynch syndrome screening" von Chai, Teresa S, Rodgers-Fouche, Linda H, Mattia, Anthony R, Chung, Daniel C

Volltext

Finding a Balance: Reconciling the Needs of the Institution, Patient, and Genetic Counselor for Optimal Resource Utilization von Patel, Devanshi, Blouch, Erica L., Rodgers-Fouché, Linda H., Emmet, Margaret M., Shannon, Kristen M.

Volltext

Current chemoprevention approaches in Lynch syndrome and Familial adenomatous polyposis: a global clinical practice survey von Mraz, Kathryn A, Hodan, Rachel, Rodgers-Fouche, Linda, Arora, Sanjeevani, Balaguer, Francesc, Guillem, Jose G, Jeter, Joanne M, Kanth, Priyanka, Li, Dan, Liska, David, Melson, Joshua, Perez, Kimberly, Ricker, Charite, Shirts, Brian H, Vilar, Eduardo, Katona, Bryson W, Dominguez-Valentin, Mev

Volltext

Germline CDH1 Variants and Lifetime Cancer Risk von Ryan, Carrie E, Fasaye, Grace-Ann, Gallanis, Amber F, Gamble, Lauren A, McClelland, Paul H, Duemler, Anna, Samaranayake, Sarah G, Blakely, Andrew M, Drogan, Christine M, Kingham, Kerry, Patel, Devanshi, Rodgers-Fouche, Linda, Siegel, Ava, Kupfer, Sonia S, Ford, James M, Chung, Daniel C, Dowty, James G, Sampson, Joshua, Davis, Jeremy L

Volltext